|
DPY19L4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.14099999999995E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.79620000004566E-06 |
| Normal-vs-Stage2 |
2.735100E-03 |
| Normal-vs-Stage3 |
4.123000E-03 |
| Normal-vs-Stage4 |
1.924360E-01 |
| Stage1-vs-Stage2 |
5.579600E-01 |
| Stage1-vs-Stage3 |
2.684600E-01 |
| Stage1-vs-Stage4 |
1.356050E-01 |
| Stage2-vs-Stage3 |
7.342800E-01 |
| Stage2-vs-Stage4 |
3.476800E-01 |
| Stage3-vs-Stage4 |
4.614800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47559999999591E-05 |
| Normal-vs-AfricanAmerican |
6.21659999999746E-05 |
| Normal-vs-Asian |
1.156810E-01 |
| Caucasian-vs-AfricanAmerican |
8.433400E-01 |
| Caucasian-vs-Asian |
5.409600E-01 |
| AfricanAmerican-vs-Asian |
4.808800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.63539999945506E-07 |
| Normal-vs-Female |
1.394010E-02 |
| Male-vs-Female |
1.026120E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.000030E-04 |
| Normal-vs-Extreme_Weight |
1.17050000003616E-06 |
| Normal-vs-Obese |
4.761600E-03 |
| Normal-vs-Extreme_Obese |
1.055310E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.198600E-01 |
| Normal_Weight-vs-Obese |
2.634200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.166000E-01 |
| Extreme_Weight-vs-Obese |
3.278300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.750000E-01 |
| Obese-vs-Extreme_Obese |
2.719400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.888800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.600450E-03 |
| Normal-vs-Age(61-80Yrs) |
1.46139999990247E-07 |
| Normal-vs-Age(81-100Yrs) |
5.208500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.046200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.043400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.260500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.681200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.663010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.123800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.84490000000915E-05 |
| Normal-VS-Type2 PRCC |
7.02299995936073E-09 |
| Normal-VS-KIRP CIMP |
6.701200E-01 |
| Normal-VS-Unclassified PRCC |
2.635600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.000400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.297900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.406400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.22750000000005E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.385600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.777800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.568899951238E-09 |
| Normal-vs-N1 |
1.693640E-01 |
| Normal-vs-N2 |
3.618600E-01 |
| N0-vs-N1 |
9.502300E-03 |
| N0-vs-N2 |
9.365500E-02 |
| N1-vs-N2 |
9.248800E-01 |
|
|
